BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 29903783)

  • 1. Availability and affordability of biologic versus non-biologic anticancer medicines: a cross-sectional study in Punjab, Pakistan.
    Saqib A; Iftikhar S; Sarwar MR
    BMJ Open; 2018 Jun; 8(6):e019015. PubMed ID: 29903783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan.
    Sarwar MR; Iftikhar S; Saqib A
    BMC Cancer; 2018 Jan; 18(1):14. PubMed ID: 29298681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
    Zhu Y; Wang Y; Sun X; Li X
    Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31623326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
    PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability, prices and affordability of selected essential medicines in Jordan: a national survey.
    Alefan Q; Amairi R; Tawalbeh S
    BMC Health Serv Res; 2018 Oct; 18(1):787. PubMed ID: 30340486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
    Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
    PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
    Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
    BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability and affordability of anticancer medicines at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania.
    Yohana E; Kamuhabwa A; Mujinja P
    East Afr J Public Health; 2011 Mar; 8(1):52-7. PubMed ID: 22066285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability, prices and affordability of essential medicines: A cross-sectional survey in Hanam province, Vietnam.
    Nguyen HTT; Dinh DX; Nguyen TD; Nguyen VM
    PLoS One; 2021; 16(11):e0260142. PubMed ID: 34793554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.
    Dabare PR; Wanigatunge CA; Beneragama BH
    BMC Public Health; 2014 Aug; 14():817. PubMed ID: 25103467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability, prices and affordability of essential medicines in Zhejiang Province, China.
    Dong Z; Tao Q; Yan B; Sun G
    PLoS One; 2020; 15(11):e0241761. PubMed ID: 33232336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Yang C; Jiang M; Zhao M; Ji W; Aziz MM; Khan FU; Gillani AH; Atif N; Fang Y; Babar ZUD
    BMJ Open; 2020 Oct; 10(10):e034720. PubMed ID: 33033079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.
    Ocran Mattila P; Biritwum RB; Babar ZU
    PLoS One; 2023; 18(5):e0279817. PubMed ID: 37134123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan.
    Bibi M; Haq NU; Kareem A; Ullah H; Baloch N; Rehman G; Nasim A
    Int J Public Health; 2022; 67():1604375. PubMed ID: 35872706
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicine prices, availability, and affordability in the Shaanxi Province in China: implications for the future.
    Jiang M; Zhou Z; Wu L; Shen Q; Lv B; Wang X; Yang S; Fang Y
    Int J Clin Pharm; 2015 Feb; 37(1):12-7. PubMed ID: 25425142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessibility of Medicines for Children: A Systematic Review.
    Chen Z; Li S; Zeng L; Liu Y; Zhang M; Choonara I; Zhang L
    Front Pharmacol; 2021; 12():691606. PubMed ID: 34421594
    [No Abstract]   [Full Text] [Related]  

  • 17. Access to Essential Cardiovascular Medicines in Pakistan: A National Survey on the Availability, Price, and Affordability, Using WHO/HAI Methodology.
    Saeed A; Saeed F; Saeed H; Saleem Z; Yang C; Chang J; Jiang M; Zhao M; Saqlain M; Ji W; Aziz MM; Lambojon K; Gillani AH; Hayat K; Gul S; Fang Y; Babar ZU
    Front Pharmacol; 2020; 11():595008. PubMed ID: 33708114
    [No Abstract]   [Full Text] [Related]  

  • 18. The availability, price and affordability of antidiabetic drugs in Hubei province, China.
    Gong S; Cai H; Ding Y; Li W; Juan X; Peng J; Jin S
    Health Policy Plan; 2018 Oct; 33(8):937-947. PubMed ID: 30215707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
    Osuafor NG; Ukwe CV; Okonta M
    PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prices, availability and affordability of medicines in Rwanda.
    Bizimana T; Kayumba PC; Heide L
    PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.